FDA limits Johnson and Johnson Vaccine due to blood clot risk
By Herman James / May 05, 2022 / marketsanity.com / Article Link
FDA, Released on 5/5/22
Today, the U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or
FDA limits Johnson and Johnson Vaccine due to blood clot risk added by Herman James on 05/05/2022View all posts by Herman James ?+'
Recent News
Big Gold production declining, revenue surging, costs flat
February 23, 2026 / www.canadianminingreport.com
Gold stocks rise with majors outpaced by juniors
February 23, 2026 / www.canadianminingreport.com
Agnico Eagle's production dip and higher costs offset by jump in gold
February 17, 2026 / www.canadianminingreport.com
Barrick, Agnico Eagle report extremely strong Q4/25 results
February 17, 2026 / www.canadianminingreport.com
Metals far outpacing tech over past year
February 09, 2026 / www.canadianminingreport.com